{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-001060","form_type":"8-K","ticker":"IBO","cik":"0001834105","company_name":"IMPACT BIOMEDICAL INC.","filed_at":"2025-03-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.169329+00:00","generated_at":"2026-05-24T03:16:03.407908+00:00","sec_items":["1.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Impact Biomedical settles $8.7M debt with 2.4M shares at $3.60/share","bullets":["Debt conversion with DSS Inc. settles $8,697,142.80 of the $13,176,477.03 principal balance.","Issued 2,415,873 shares of common stock at $3.60 per share, equal to March 24 closing price.","Original promissory note principal was $12,000,000; amended September 16, 2024.","Settlement reduces outstanding debt by 66% while diluting existing shareholders by approximately 2.4M shares."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-001060","json":"https://secwatch.observer/filing/0001641172-25-001060.json","markdown":"https://secwatch.observer/filing/0001641172-25-001060.md","text":"https://secwatch.observer/filing/0001641172-25-001060.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1834105/000164117225001060/0001641172-25-001060-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1834105/000164117225001060/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T03:16:03.407908+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}